Determining the Impact of Scaling up Mass Testing, Treatment and Tracking on Malaria Prevalence in Ghana
NCT04301531 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 5861
Last updated 2023-05-06
Summary
Globally, malaria prevalence in 2016 was reported to have increased with 445,000 deaths, 91% of which occurred in sub-Sahara Africa with more than 75% being children. Individuals who carry the malaria parasite can either be symptomatic (showing signs and symptoms) or asymptomatic (without signs and symptoms). Asymptomatic malaria parasitaemia pose a very serious threat to malaria control efforts as they serve as reservoirs that fuel the transmission process. Therefore, interventions that target community-wide clearance of asymptomatic parasitaemia can drastically reduce malaria prevalence in the population and lead to elimination especially in endemic areas. Mass parasite clearance can deplete the parasite reservoirs and lower the transmission potential.
Efforts are ongoing to scale-up interventions that work such as use of Long Lasting Insecticidal Nets (LLIN), Intermittent Preventive Treatment in children (IPTc), and test, treat and track (TTT). However, there is need for mass testing, treatment and tracking (MTTT) of the whole population to reduce the parasite load before implementing the aforementioned interventions. Though, Seasonal Malaria Chemoprophylaxis (SMC) is adopted for selected localities in Ghana, the impact of such interventions could be enhanced, if combined with MTTT at baseline to reduce the parasite load. IPT of children in Ghana has demonstrated a parasite load reduction from 25% to 1%. However, unanswered questions include - could this be scaled up? What can be the coverage? What is needed for MTTT scale -up? In a pilot in Ghana, a coverage of more than 75% was achieved in target communities and reduced asymptomatic parasitaemia by 24% from July 2017 to July 2018. It is important to generate time series data to better analyse and understand the prevalence trends as well as the bottlenecks.
In designing interventions that aim at reducing the burden of malaria in children under five, for example, MTTT has largely been left out. This study explores the scale-up of interventions that work using community volunteers, hypothesising that implementing MTTT complemented by community-based management can reduce the prevalence of asymptomatic malaria parasite carriage in endemic communities. The effect of the interventions will be observed by comparing baseline data to evaluation data. This study will document the challenges and bottlenecks associated with scaling-up of MTTT to inform future efforts to scale-up the intervention.
Conditions
- Malaria Asymptomatic Parasitaemia
Interventions
- OTHER
-
Mass testing using RDTs
To determined the prevalence of asymptomatic malaria parasitaemia. In arm 1 all participants will be tested six times over the study period while in arm 2 the participants will be only be tested at baseline and evaluation.
- DRUG
-
Treatment for all cases confirmed positive malaria cases with ACTs
During each mass testing, all confirmed positive cases are treated in both arms.
- OTHER
-
Determination of Hb
Hb of all children in the subgroup study are measured using a haemocure photometer.
- OTHER
-
Household survey
Determine the prevalence of febrile illnesses among children in the subgroup study
- OTHER
-
Community-base management of malaria
Between interventions, participant who become febrile are tested and treated if confirmed positive for malaria by CHWs
Sponsors & Collaborators
-
Ghana National Malaria Control Programme
collaborator UNKNOWN -
Communities
collaborator UNKNOWN -
Noguchi Memorial Institute for Medical Research
lead OTHER
Principal Investigators
-
Ndong Ignatius Cheng, PhD · Noguchi Memorial Institute for Medical Research
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 2 Months
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-03-01
- Primary Completion
- 2021-11-30
- Completion
- 2023-01-31
Countries
- Ghana
Study Locations
More Related Trials
-
Intermittent Preventive Treatment for Malaria in Infants in Navrongo Ghana
NCT00857077 ·Status: COMPLETED ·Phase: NA
-
Intermittent Preventive Treatment (IPTp) Versus Rapid Diagnostic Testing (RDT) and Treatment of Malaria in Pregnancy
NCT00432367 ·Status: COMPLETED ·Phase: PHASE3
-
Feasibility and Safety of Combining Anti-malarial With Deworming Drugs in African Children
NCT05354258 ·Status: UNKNOWN ·Phase: NA
-
Efficacy of Amodiaquine in the Treatment of Uncomplicated Falciparum Malaria in Young Children of Burkina Faso
NCT00261222 ·Status: COMPLETED ·Phase: PHASE2
-
Non-malarial Febrile Illness in Children in Areas of Perennial Malaria Transmission
NCT01043744 ·Status: COMPLETED ·Phase: NA
-
Seasonal Malaria Chemoprevention With or Without Lipid-based Nutrient Supplement in Children Aged 6-59 Months in Mali
NCT03035305 ·Status: COMPLETED ·Phase: NA
-
Gut and Azithromycin Mechanisms in Infants and Children II
NCT04315272 ·Status: COMPLETED ·Phase: PHASE4
-
Malaria Prevalence in Children
NCT00322816 ·Status: COMPLETED
-
Impact of Insecticide-treated Curtains on Antimalarial Drug Resistance
NCT00169078 ·Status: COMPLETED ·Phase: NA
-
CHILD (Child Health and Infection With Low Density) Malaria
NCT05567016 ·Status: COMPLETED ·Phase: NA
-
Control of Pregnancy Associated Malaria With Intermittent Preventive Treatment
NCT00258024 ·Status: COMPLETED ·Phase: NA
-
Pharmacokinetics of Dihydroartemisinin-Piperaquine in the Treatment of Uncomplicated Malaria in Children in Burkina Faso
NCT00845533 ·Status: COMPLETED ·Phase: PHASE4
-
Host Immune Dynamics Following Seasonal Malaria Chemoprevention in African Children
NCT06524336 ·Status: ACTIVE_NOT_RECRUITING
-
Age of Exposure and Immunity to Malaria in Infants
NCT00231452 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Implementation and Effectiveness of Intermittent Preventive Treatment for Malaria Using Dihydroartemisinin-piperaquine on Reducing Malaria Burden in School Aged Children in Tanzania
NCT04245033 ·Status: COMPLETED ·Phase: PHASE4
-
A Study Assessing the Safety, Efficacy, and Impact of GlaxoSmithKline Biologicals' RTS, S/AS01E Malaria Vaccine in Young Children Across Sub-Saharan Africa
NCT03855995 ·Status: COMPLETED
-
Epidemiology Study of Malaria Transmission Intensity in Sub-Saharan Africa
NCT02251704 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of Rapid Diagnosis Tests in Imported Malaria
NCT00451269 ·Status: COMPLETED
-
Africa Ready Malaria Screening
NCT06153862 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Intermittent Preventive Treatment With Antimalarials in Kenyan Infants
NCT00111163 ·Status: COMPLETED ·Phase: NA
-
School-Based Treatment With ACT to Reduce Transmission
NCT02009215 ·Status: COMPLETED ·Phase: PHASE4
-
Algorithm Using a Rapid Diagnostic Test for the Management of Childhood Febrile Diseases.
NCT05285657 ·Status: COMPLETED ·Phase: NA
-
Malaria Transmission and Immunity in Highland Kenya
NCT00393757 ·Status: COMPLETED
-
Comparing Chemoprevention Drugs for School-based Malaria Control
NCT05980156 ·Status: COMPLETED ·Phase: PHASE4
-
Effectiveness of Intermittent Preventive Treatment for Malaria in Children
NCT00119132 ·Status: COMPLETED ·Phase: PHASE2/PHASE3